Treating chronic lumbago with MLS® therapy. A controlled trial

Scarica

A. Venturin, M. Ortolani
Scientific Report MLS®, 2004

Lumbar pain is a symptom of variable etiology that is very widespread amongst the adult population, especially young adults in industrialized countries. Numerous epidemiological studies have been carried out over recent years, with varied findings as regards the incidence and social impact of this disease. This lack of accurate data is linked to the different sources of information, the very definition of lumbar pain, the various forms of behavior of sufferers depending on insurance systems and, finally, the different treatments used in different countries. In order to get a clear picture of the capacity of this phenomenon, it will be useful to provide some information on the prevalence of the disease, especially in the work environment, and its consequent economic impact. In Great Britain, for example, 46% of a random sample of the general population claims to have suffered from lumbago at least once in their lives. Also in Great Britain, there were 15 million medical visits for lumbago in 1993, leading to 1.5 million spinal X-rays, one million patients treated with rehabilitative physiotherapy, 100,000 hospital admissions, 30,000 day-hospital days and 24,000 surgical operations. Lumbago costs the country an estimated 520 million Euro/year.